145 related articles for article (PubMed ID: 24071868)
1. Developmentally restricted differentiation antigens are targets for immunotherapy in epithelial ovarian carcinoma.
Godoy H; Mhawech-Fauceglia P; Beck A; Miliotto A; Miller A; Lele S; Odunsi K
Int J Gynecol Pathol; 2013 Nov; 32(6):536-40. PubMed ID: 24071868
[TBL] [Abstract][Full Text] [Related]
2. A cytoplasmic protein, bystin, interacts with trophinin, tastin, and cytokeratin and may be involved in trophinin-mediated cell adhesion between trophoblast and endometrial epithelial cells.
Suzuki N; Zara J; Sato T; Ong E; Bakhiet N; Oshima RG; Watson KL; Fukuda MN
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5027-32. PubMed ID: 9560222
[TBL] [Abstract][Full Text] [Related]
3. Trophinin, tastin, and bystin: a complex mediating unique attachment between trophoblastic and endometrial epithelial cells at their respective apical cell membranes.
Fukuda MN; Nozawa S
Semin Reprod Endocrinol; 1999; 17(3):229-34. PubMed ID: 10797941
[TBL] [Abstract][Full Text] [Related]
4. Expression of trophinin, tastin, and bystin by trophoblast and endometrial cells in human placenta.
Suzuki N; Nakayama J; Shih IM; Aoki D; Nozawa S; Fukuda MN
Biol Reprod; 1999 Mar; 60(3):621-7. PubMed ID: 10026108
[TBL] [Abstract][Full Text] [Related]
5. Recent molecular approaches to elucidate the mechanism of embryo implantation: trophinin, bystin, and tastin as molecules involved in the initial attachment of blastocysts to the uterus in humans.
Aoki R; Fukuda MN
Semin Reprod Med; 2000; 18(3):265-71. PubMed ID: 11299965
[TBL] [Abstract][Full Text] [Related]
6. Bystin in perineural invasion of prostate cancer.
Ayala GE; Dai H; Li R; Ittmann M; Thompson TC; Rowley D; Wheeler TM
Prostate; 2006 Feb; 66(3):266-72. PubMed ID: 16245277
[TBL] [Abstract][Full Text] [Related]
7. Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.
Tchabo NE; Mhawech-Fauceglia P; Caballero OL; Villella J; Beck AF; Miliotto AJ; Liao J; Andrews C; Lele S; Old LJ; Odunsi K
Cancer Immun; 2009 Aug; 9():6. PubMed ID: 19705800
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
10. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
[TBL] [Abstract][Full Text] [Related]
11. Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors.
Garcia-Soto AE; Schreiber T; Strbo N; Ganjei-Azar P; Miao F; Koru-Sengul T; Simpkins F; Nieves-Neira W; Lucci J; Podack ER
Gynecol Oncol; 2017 Jun; 145(3):413-419. PubMed ID: 28392126
[TBL] [Abstract][Full Text] [Related]
12. Bystin as a novel marker for reactive astrocytes in the adult rat brain following injury.
Sheng J; Yang S; Xu L; Wu C; Wu X; Li A; Yu Y; Ni H; Fukuda M; Zhou J
Eur J Neurosci; 2004 Aug; 20(4):873-84. PubMed ID: 15305856
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.
Deng B; Zhao Y; Gou W; Chen S; Mao X; Takano Y; Zheng H
Tumour Biol; 2013 Oct; 34(5):2617-24. PubMed ID: 23657964
[TBL] [Abstract][Full Text] [Related]
14. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
15. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.
Hylander B; Repasky E; Shrikant P; Intengan M; Beck A; Driscoll D; Singhal P; Lele S; Odunsi K
Gynecol Oncol; 2006 Apr; 101(1):12-7. PubMed ID: 16263157
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
17. Sperm protein 17: clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond.
Chiriva-Internati M
Int Rev Immunol; 2011; 30(2-3):138-49. PubMed ID: 21557640
[TBL] [Abstract][Full Text] [Related]
18. The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.
Kersual N; Garambois V; Chardès T; Pouget JP; Salhi I; Bascoul-Mollevi C; Bibeau F; Busson M; Vié H; Clémenceau B; Behrens CK; Estupina P; Pèlegrin A; Navarro-Teulon I
MAbs; 2014; 6(5):1314-26. PubMed ID: 25517316
[TBL] [Abstract][Full Text] [Related]
19. The Bysl gene product, bystin, is essential for survival of mouse embryos.
Aoki R; Suzuki N; Paria BC; Sugihara K; Akama TO; Raab G; Miyoshi M; Nadano D; Fukuda MN
FEBS Lett; 2006 Nov; 580(26):6062-8. PubMed ID: 17055491
[TBL] [Abstract][Full Text] [Related]
20. SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.
Tammela J; Jungbluth AA; Qian F; Santiago D; Scanlan MJ; Keitz B; Driscoll D; Rodabaugh K; Lele S; Old LJ; Odunsi K
Cancer Immun; 2004 Oct; 4():10. PubMed ID: 15487888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
